HBK Investments’s Agilon Health AGL Stock Holding History

HBK Investments’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-949	Closed	-$622K	–	718
2021 Q3	$622K	Buy	+949	New	+$811K	﹤0.01%	541

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

HBK Investments's AGL Position: Q4 2021 in Review

HBK Investments sold out of Agilon Health (AGL) in Q4 2021, closing a stake of 949 shares — an estimated $622K sold.

HBK Investments first reported a position in AGL in Q3 2021 and held it in 1 quarter. The position peaked at $622K in Q3 2021. 132 funds tracked by Wall St. Rank hold AGL as of Q4 2021.

HBK Investments reported no remaining Agilon Health position as of Q4 2021 after selling out during the quarter.
HBK Investments sold 949 Agilon Health shares in Q4 2021, an estimated $622K.
HBK Investments first reported a position in Agilon Health in Q3 2021 and held it in 1 quarter.
HBK Investments's Agilon Health position peaked at $622K in Q3 2021.
132 funds tracked by Wall St. Rank held Agilon Health as of Q4 2021.

Based on HBK Investments's 13F filing for Q4 2021, filed 14 Feb 2022.